These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30652926)

  • 41. Incidence and clinical features of hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) and spectrum of mevalonate kinase (MVK) mutations in German children.
    Lainka E; Neudorf U; Lohse P; Timmann C; Bielak M; Stojanov S; Huss K; von Kries R; Niehues T
    Rheumatol Int; 2012 Oct; 32(10):3253-60. PubMed ID: 22038276
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A case of hyperimmunoglobulinemia d syndrome successfully treated with canakinumab.
    Tsitsami E; Papadopoulou C; Speletas M
    Case Rep Rheumatol; 2013; 2013():795027. PubMed ID: 23691418
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Defective Protein Prenylation in a Spectrum of Patients With Mevalonate Kinase Deficiency.
    Munoz MA; Jurczyluk J; Simon A; Hissaria P; Arts RJW; Coman D; Boros C; Mehr S; Rogers MJ
    Front Immunol; 2019; 10():1900. PubMed ID: 31474985
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cyclic Fevers in Adult Diagnosed As Hyperimmunoglobulin D Syndrome.
    Reji M; Thapa R
    Cureus; 2022 Apr; 14(4):e23878. PubMed ID: 35530832
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of Continuous Interleukin 1 Blockade in Mevalonate Kinase Deficiency: A Multicenter Retrospective Study in 13 Adult Patients and Literature Review.
    Deshayes S; Georgin-Lavialle S; Hot A; Durel CA; Hachulla E; Rouanes N; Audia S; Le Gallou T; Quartier P; Urbanski G; Messer L; Klein S; de Boysson H; Bienvenu B; Grateau G; Aouba A
    J Rheumatol; 2018 Mar; 45(3):425-429. PubMed ID: 29335349
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mevalonate kinase deficiency in two sisters with therapeutic response to anakinra: case report and review of the literature.
    Campanilho-Marques R; Brogan PA
    Clin Rheumatol; 2014 Nov; 33(11):1681-4. PubMed ID: 24531849
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A case report of mevalonate kinase deficiency in a 14-month-old female with fevers and lower extremity weakness.
    Coppola T; Becken B; Van Mater H; McDonald MT; Panayotti GM
    BMC Pediatr; 2019 Jul; 19(1):245. PubMed ID: 31325964
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel mutations causing hyperimmunoglobulin D and periodic fever syndrome.
    Sinha A; Waterham HR; Sreedhar KV; Jain V
    Indian Pediatr; 2012 Jul; 49(7):583-5. PubMed ID: 22885443
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spectrum of clinical features and genetic variants in mevalonate kinase (MVK) gene of South Indian families suffering from Hyperimmunoglobulin D Syndrome.
    Govindaraj GM; Jain A; Peethambaran G; Bhoyar RC; Vellarikkal SK; Ganapati A; Sandhya P; Edavazhippurath A; Dhanasooraj D; Puthenpurayil JM; Chakkiyar K; Mishra A; Batra A; Punnen A; Kumar S; Sivasubbu S; Scaria V
    PLoS One; 2020; 15(8):e0237999. PubMed ID: 32822427
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Hyperimmunoglobulinemia D and periodic fever syndrome].
    Sakai H; Heike T
    Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(5):382-7. PubMed ID: 22041426
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A clinical criterion to exclude the hyperimmunoglobulin D syndrome (mild mevalonate kinase deficiency) in patients with recurrent fever.
    Steichen O; van der Hilst J; Simon A; Cuisset L; Grateau G
    J Rheumatol; 2009 Aug; 36(8):1677-81. PubMed ID: 19531764
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cutaneous manifestations in mevalonate kinase deficient patients treated with canakinumab.
    Conte M; Pastore S; Berti I; Taddio A; Tommasini A
    Clin Exp Rheumatol; 2020; 38(4):760-762. PubMed ID: 32324125
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacological treatment options for cryopyrin-associated periodic syndromes.
    Landmann EC; Walker UA
    Expert Rev Clin Pharmacol; 2017 Aug; 10(8):855-864. PubMed ID: 28586272
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Phenotype and Genotype of Mevalonate Kinase Deficiency: A Series of 114 Cases From the Eurofever Registry.
    Ter Haar NM; Jeyaratnam J; Lachmann HJ; Simon A; Brogan PA; Doglio M; Cattalini M; Anton J; Modesto C; Quartier P; Hoppenreijs E; Martino S; Insalaco A; Cantarini L; Lepore L; Alessio M; Calvo Penades I; Boros C; Consolini R; Rigante D; Russo R; Pachlopnik Schmid J; Lane T; Martini A; Ruperto N; Frenkel J; Gattorno M;
    Arthritis Rheumatol; 2016 Nov; 68(11):2795-2805. PubMed ID: 27213830
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Homozygous V377I mutation causing mevalonate kinase.
    Brito T; Banganho D; Pedrosa C; Farela Neves J
    BMJ Case Rep; 2022 Apr; 15(4):. PubMed ID: 35387795
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [MVK gene abnormality and new approach to treatment of hyper IgD syndrome and periodic fever syndrome].
    Naruto T
    Nihon Rinsho Meneki Gakkai Kaishi; 2007 Apr; 30(2):86-9. PubMed ID: 17473510
    [TBL] [Abstract][Full Text] [Related]  

  • 57. When neonatal inflammation does not mean infection: an early-onset mevalonate kinase deficiency with interstitial lung disease.
    Pietrasanta C; Minoia F; Torreggiani S; Ronchi A; Gattorno M; Volpi S; Ceccherini I; Mosca F; Filocamo G; Pugni L
    Clin Immunol; 2019 Aug; 205():25-28. PubMed ID: 31096039
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The long and winding road in pharmaceutical development of canakinumab from rare genetic autoinflammatory syndromes to myocardial infarction and cancer.
    Gram H
    Pharmacol Res; 2020 Apr; 154():104139. PubMed ID: 30648616
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hyper-IgD syndrome or mevalonate kinase deficiency.
    Stoffels M; Simon A
    Curr Opin Rheumatol; 2011 Sep; 23(5):419-23. PubMed ID: 21760510
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phenotypic diversity, disease progression, and pathogenicity of MVK missense variants in mevalonic aciduria.
    Brennenstuhl H; Nashawi M; Schröter J; Baronio F; Beedgen L; Gleich F; Jeltsch K; von Landenberg C; Martini S; Simon A; Thiel C; Tsiakas K; Opladen T; Kölker S; Hoffmann GF; Haas D;
    J Inherit Metab Dis; 2021 Sep; 44(5):1272-1287. PubMed ID: 34145613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.